Skip to main content
OpenTrials
Completed

NCT Number: NCT04973631

The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study

Gastric cancer (GC) is more prevalent in males than in females. One of these differences could be the effect of sex hormones such as estrogens. However, few reports have been reported regarding sex and age differences of incidence and survival of GC. The aim of this study was to evaluate the effect of sex and age on the incidence and survival of GC. And we would like to further analyze single GC and synchronous multiple GC, EBV, etc.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Gastric cancer

Exclusion criteria

  • Gastric MALTOMA
  • Gastric Lymphoma
  • Gastrointestinal stromal tumors (GISTs)

Treatment and study plan

Sex, Age

Genetic

Evaluate the effect of sex and age on the incidence and survival of GC.

Primary outcomes

  1. Survival rate

    Time frame: up to 120 months

    Survival rate of gastric cancer on sex and age

  2. histologic type

    Time frame: about 18 years

    histologic type of gastric cancer on sex and age

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

The Effects of Sex and Age Differences on Gastric Cancer in Terms of Incidence of Histologic Subtypes and Survival Rate: a Retrospective Study

Important dates

Study start
2003
Primary completion
2021
Study completion
2022
First posted
Jul 22, 2021
Registry last updated
Apr 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.